While current studies, such as the one published in 2021 in the Endocrine Journal, indicate that Ozempic patients may be at a higher risk of blood clots, more research is needed to definitively determine causality
Underlying Conditions : Chronic illnesses like diabetes or a history of kidney problems will also be discussed, as they can increase your risk of infections
Now, with the FDA's recent approval of Foundayo (orforglipron), Eli Lilly has introduced something that could shift the entire landscape: an oral GLP-1 receptor agonist that you simply swallow like any other daily pill
Patients are moving away from unsustainable fad diets and unregulated supplements, opting instead for medically supervised peptide therapies grounded in clinical evidence
Patients were excluded if there was a history of bariatric surgery or use of a branded AOM that was approved by the FDA for chronic use (phentermine/topiramate [Qsymia], bupropion/naltrexone [Contrave], liraglutide [Saxenda] or orlistat [Xenical]) or other GLP1 RAs (liraglutide [Victoza], dulaglutide [Trulicity], exenatide [Byetta, Bydureon, Bydureon BCise] or lixisenatide [Adlyxin]) during the baseline period
